Security key
03969K108
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)
CUSIP: 03969K108
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 123,454,843
- Total 13F shares
- 49,075,739
- Share change
- +789,414
- Total reported value
- $1,045,833,934
- Put/Call ratio
- 44%
- Price per share
- $21.31
- Number of holders
- 112
- Value change
- +$17,642,019
- Number of buys
- 70
- Number of sells
- 31
Report period
Q2 2022
Institutions
112
Top holders
10
ARQT full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
6.8%
|
8,434,232
|
$162,443,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
6.1%
|
7,557,593
|
$145,558,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
4.9%
|
6,073,850
|
$116,982,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.5%
|
4,315,802
|
$83,124,000 | — | 31 Mar 2022 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
3.2%
|
3,979,292
|
$76,641,000 | — | 31 Mar 2022 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.4%
|
1,784,005
|
$34,360,000 | — | 31 Mar 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.4%
|
1,697,849
|
$32,701,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,531,098
|
$29,489,000 | — | 31 Mar 2022 | |
| Logos Global Management LP |
13F
|
Company |
1.2%
|
1,500,000
|
$28,890,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.96%
|
1,189,500
|
$22,910,000 | — | 31 Mar 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.73%
|
895,503
|
$17,247,000 | — | 31 Mar 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.53%
|
659,816
|
$12,708,000 | — | 31 Mar 2022 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.51%
|
623,836
|
$12,015,000 | — | 31 Mar 2022 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.49%
|
609,648
|
$11,741,000 | — | 31 Mar 2022 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.46%
|
569,041
|
$10,960,000 | — | 31 Mar 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.42%
|
524,559
|
$10,103,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
509,381
|
$9,810,000 | — | 31 Mar 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.4%
|
495,450
|
$9,544,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.36%
|
448,702
|
$8,642,000 | — | 31 Mar 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.35%
|
430,262
|
$8,285,000 | — | 31 Mar 2022 | |
| AXA S.A. |
13F
|
Company |
0.29%
|
354,943
|
$6,836,202 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.21%
|
258,937
|
$4,987,000 | — | 31 Mar 2022 | |
| MPM BioImpact LLC |
13F
|
Company |
0.21%
|
258,500
|
$4,979,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.18%
|
227,383
|
$4,378,000 | — | 31 Mar 2022 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.18%
|
219,136
|
$4,221,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
216,380
|
$3,568,000 | — | 31 Mar 2022 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.17%
|
212,500
|
$4,093,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
200,964
|
$3,871,000 | — | 31 Mar 2022 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.15%
|
189,363
|
$3,647,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
176,700
|
$3,403,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.11%
|
138,735
|
$2,672,000 | — | 31 Mar 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.11%
|
131,633
|
$2,535,000 | — | 31 Mar 2022 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.1%
|
129,276
|
$2,490,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
100,126
|
$1,928,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
97,441
|
$1,878,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
96,346
|
$1,856,000 | — | 31 Mar 2022 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.07%
|
91,988
|
$1,773,000 | — | 31 Mar 2022 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.07%
|
87,369
|
$1,683,000 | — | 31 Mar 2022 | |
| Walleye Capital LLC |
13F
|
Company |
0.06%
|
75,553
|
$1,455,000 | — | 31 Mar 2022 | |
| 1492 Capital Management LLC |
13F
|
Company |
0.06%
|
75,192
|
$1,448,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
62,573
|
$1,205,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
0.05%
|
61,116
|
$1,177,094 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
59,500
|
$1,146,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.05%
|
57,259
|
$1,103,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
54,302
|
$1,046,000 | — | 31 Mar 2022 | |
| HAMILTON LANE ADVISORS LLC |
13F
|
Company |
0.04%
|
52,347
|
$1,008,000 | — | 31 Mar 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.04%
|
51,783
|
$997,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
37,938
|
$730,000 | — | 31 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
35,340
|
$681,000 | — | 31 Mar 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
33,524
|
$646,000 | — | 31 Mar 2022 |
Institutional Holders of Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) as of Q2 2022
As of 30 Jun 2022,
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,075,739 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., FMR LLC, ORBIMED ADVISORS LLC, BlackRock Inc., Bain Capital Life Sciences Investors, LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, Polar Capital Holdings Plc, STATE STREET CORP, and Logos Global Management LP.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
106
Q2 2022 holders
112
Holder diff
6
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.